People taking GLP-1 drugs were more likely to experience certain types of temporary hair loss within a year of starting treatment, a large new study found. Hair shedding is a known side effect of ...

There are reports that those taking the drugs, which include medications like Ozempic and Wegovy, are being diagnosed with scurvy, an illness once common in the 17th and 18th centuries that is now ...

GLP-1 therapies continue to reshape chronic disease treatment, triggering regulatory updates, new clinical findings and intensifying competition across the pharmaceutical market. On Jan. 13, the FDA ...

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...

With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a ...

Hims & Hers Health, Inc. is facing increasing regulatory pressure regarding its compounded GLP-1 offering. The GLP-1 revenue stream has been significant for HIMS, but not the only source of growth.

Serena Williams' Super Bowl commercial, which was an ad promoting GLP-1 weight loss drugs and the telehealth company Ro, has been met with criticism online after it aired on Sunday. Williams said in ...

Credit: Getty Images Two reproductive endocrinologists provide insight on the association between GLP-1 medication use and fertility. Clinicians say that improved fertility in patients using GLP-1s is ...

Americans watching the Super Bowl today will hear a tantalizing pitch: You, too, can live like the rich. All you need is a way to order up health care the way they do. A new ad scheduled to air during ...

The federal health agency is referring knockoff weight-loss drug provider Hims & Hers to the Justice Department for potential violations of the federal Food, Drug, and Cosmetic Act, general counsel ...

The cost of GLP-1 medications varies widely, ranging from around $199 to over $1,500. Insurance coverage for GLP-1s is more common for diabetes management than for weight loss. Consumers can ...

Where do indications for GLP-1 receptor agonists (RAs) currently stand? Experts addressed these questions at the French Nutrition Days 2025 in Lyon, France, with a focus on obesity treatment, ...